IBIO, INC. Increase (Decrease) in Accrued Interest Receivable, Net
IBIO, INC. (IBIO) reported Increase (Decrease) in Accrued Interest Receivable, Net of $80.00 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet · last filed 2026-08-28
- IBIO, INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2026-06-30 was $21.00K, a 40.00% increase year-over-year.
- IBIO, INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2026-03-31 was $20.00K, a 42.86% increase year-over-year.
- IBIO, INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2025-12-31 was $20.00K, a 42.86% increase year-over-year.
- IBIO, INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2025-09-30 was $19.00K, a 0.00% change year-over-year.
- IBIO, INC. increase (decrease) in accrued interest receivable, net for fiscal 2026 was $80.00K, a 29.03% increase from fiscal 2025.
- IBIO, INC. increase (decrease) in accrued interest receivable, net for fiscal 2025 was $62.00K, a 29.55% decline from fiscal 2024.
- IBIO, INC. increase (decrease) in accrued interest receivable, net for fiscal 2024 was $88.00K, a 17.33% increase from fiscal 2023.
- IBIO, INC. increase (decrease) in accrued interest receivable, net for fiscal 2023 was $75.00K.
| Period end | Increase (Decrease) in Accrued Interest Receivable, Net 3 month | Increase (Decrease) in Accrued Interest Receivable, Net 6 month | Increase (Decrease) in Accrued Interest Receivable, Net 9 month | Increase (Decrease) in Accrued Interest Receivable, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-28 | $41.00K derived: sum of 2 quarters · filed 2026-08-28 | $61.00K derived: sum of 3 quarters · filed 2026-08-28 | $80.00K 10-K · filed 2026-08-28 |
| 2026-03-31 | $20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-12 | $40.00K derived: sum of 2 quarters · filed 2026-05-12 | $59.00K 10-Q · filed 2026-05-12 | $74.00K derived: sum of 4 quarters · filed 2026-08-28 |
| 2025-12-31 | $20.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2026-02-10 | $39.00K 10-Q · filed 2026-02-10 | $54.00K derived: sum of 3 quarters · filed 2026-08-28 | $68.00K derived: sum of 4 quarters · filed 2026-08-28 |
| 2025-09-30 | $19.00K 10-Q/A · filed 2025-11-17 | $34.00K derived: sum of 2 quarters · filed 2026-08-28 | $48.00K derived: sum of 3 quarters · filed 2026-08-28 | $62.00K derived: sum of 4 quarters · filed 2026-08-28 |
| 2025-06-30 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-28 | $29.00K derived: sum of 2 quarters · filed 2026-08-28 | $43.00K derived: sum of 3 quarters · filed 2026-08-28 | $62.00K 10-K · filed 2026-08-28 |
| 2025-03-31 | $14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-12 | $28.00K derived: sum of 2 quarters · filed 2026-05-12 | $47.00K 10-Q · filed 2026-05-12 | $69.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $14.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2026-02-10 | $33.00K 10-Q · filed 2026-02-10 | $55.00K derived: sum of 3 quarters · filed 2026-02-10 | $77.00K derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-09-30 | $19.00K 10-Q/A · filed 2025-11-17 | $41.00K derived: sum of 2 quarters · filed 2025-11-17 | $63.00K derived: sum of 3 quarters · filed 2025-11-17 | $85.00K derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-06-30 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-05 | $44.00K derived: sum of 2 quarters · filed 2025-09-05 | $66.00K derived: sum of 3 quarters · filed 2025-09-05 | $88.00K 10-K · filed 2025-09-05 |
| 2024-03-31 | $22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-02 | $44.00K derived: sum of 2 quarters · filed 2025-05-02 | $66.00K 10-Q · filed 2025-05-02 | |
| 2023-12-31 | $22.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-10 | $44.00K 10-Q · filed 2025-02-10 | ||
| 2023-09-30 | $22.00K 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | $75.00K 10-K/A · filed 2024-09-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |